Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Melanocortin Receptor 4 Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4309313
  • |
  • 13 April, 2021
  • |
  • Global
  • |
  • 136 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Melanocortin Receptor 4 Market Status and Forecast (2016-2027)
      • 1.3.2 Global Melanocortin Receptor 4 Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Melanocortin Receptor 4 Supply by Company

    • 2.1 Global Melanocortin Receptor 4 Sales Volume by Company
    • 2.2 Global Melanocortin Receptor 4 Sales Value by Company
    • 2.3 Global Melanocortin Receptor 4 Price by Company
    • 2.4 Melanocortin Receptor 4 Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Melanocortin Receptor 4 Market Status by Category

    • 3.1 Melanocortin Receptor 4 Category Introduction
      • 3.1.1 Bremelanotide
      • 3.1.2 Corticotropin
      • 3.1.3 Cosyntropin
      • 3.1.4 Others
    • 3.2 Global Melanocortin Receptor 4 Market by Category
      • 3.2.1 Global Melanocortin Receptor 4 Sales Volume by Category (2016-2021)
      • 3.2.2 Global Melanocortin Receptor 4 Sales Value by Category (2016-2021)
      • 3.2.3 Global Melanocortin Receptor 4 Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Melanocortin Receptor 4 Market Status by End User/Segment

    • 4.1 Melanocortin Receptor 4 Segment by End User/Segment
      • 4.1.1 Metabolic Disorder
      • 4.1.2 Women's Health
      • 4.1.3 Genito Urinary System
      • 4.1.4 Infection Disease
      • 4.1.5 Others
    • 4.2 Global Melanocortin Receptor 4 Market by End User/Segment
      • 4.2.1 Global Melanocortin Receptor 4 Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Melanocortin Receptor 4 Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Melanocortin Receptor 4 Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Melanocortin Receptor 4 Market Status by Region

    • 5.1 Global Melanocortin Receptor 4 Market by Region
      • 5.1.1 Global Melanocortin Receptor 4 Sales Volume by Region
      • 5.1.2 Global Melanocortin Receptor 4 Sales Value by Region
    • 5.2 North America Melanocortin Receptor 4 Market Status
    • 5.3 Europe Melanocortin Receptor 4 Market Status
    • 5.4 Asia Pacific Melanocortin Receptor 4 Market Status
    • 5.5 Central & South America Melanocortin Receptor 4 Market Status
    • 5.6 Middle East & Africa Melanocortin Receptor 4 Market Status

    6 North America Melanocortin Receptor 4 Market Status

    • 6.1 North America Melanocortin Receptor 4 Market by Country
      • 6.1.1 North America Melanocortin Receptor 4 Sales Volume by Country (2016-2021)
      • 6.1.2 North America Melanocortin Receptor 4 Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Melanocortin Receptor 4 Market Status

    • 7.1 Europe Melanocortin Receptor 4 Market by Country
      • 7.1.1 Europe Melanocortin Receptor 4 Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Melanocortin Receptor 4 Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Melanocortin Receptor 4 Market Status

    • 8.1 Asia Pacific Melanocortin Receptor 4 Market by Country
      • 8.1.1 Asia Pacific Melanocortin Receptor 4 Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Melanocortin Receptor 4 Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Melanocortin Receptor 4 Market Status

    • 9.1 Central & South America Melanocortin Receptor 4 Market by Country
      • 9.1.1 Central & South America Melanocortin Receptor 4 Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Melanocortin Receptor 4 Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Melanocortin Receptor 4 Market Status

    • 10.1 Middle East & Africa Melanocortin Receptor 4 Market by Country
      • 10.1.1 Middle East & Africa Melanocortin Receptor 4 Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Melanocortin Receptor 4 Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Melanocortin Receptor 4 Manufacturing Cost Analysis
    • 11.5 Melanocortin Receptor 4 Sales Channel and Distributors Analysis
      • 11.5.1 Melanocortin Receptor 4 Sales Channel
      • 11.5.2 Melanocortin Receptor 4 Distributors
    • 11.6 Melanocortin Receptor 4 Downstream Major Buyers

    12 Global Melanocortin Receptor 4 Market Forecast by Category and by End User/Segment

    • 12.1 Global Melanocortin Receptor 4 Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Melanocortin Receptor 4 Forecast by Category
      • 12.2.1 Global Melanocortin Receptor 4 Sales Volume Forecast by Category
      • 12.2.2 Global Melanocortin Receptor 4 Sales Value Forecast by Category
      • 12.2.3 Global Melanocortin Receptor 4 Price Forecast by Category
    • 12.3 Global Melanocortin Receptor 4 Forecast by End User/Segment
      • 12.3.1 Global Melanocortin Receptor 4 Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Melanocortin Receptor 4 Sales Value Forecast by End User/Segment
      • 12.3.3 Global Melanocortin Receptor 4 Price Forecast by End User/Segment

    13 Global Melanocortin Receptor 4 Market Forecast by Region/Country

    • 13.1 Global Melanocortin Receptor 4 Market Forecast by Region (2022-2027)
      • 13.1.1 Global Melanocortin Receptor 4 Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Melanocortin Receptor 4 Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Rhythm Pharmaceuticals, Inc.
      • 14.1.1 Company Information
      • 14.1.2 Melanocortin Receptor 4 Product Introduction
      • 14.1.3 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Retrophin Inc.
      • 14.2.1 Company Information
      • 14.2.2 Melanocortin Receptor 4 Product Introduction
      • 14.2.3 Retrophin Inc. Melanocortin Receptor 4 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Pfizer Inc.
      • 14.3.1 Company Information
      • 14.3.2 Melanocortin Receptor 4 Product Introduction
      • 14.3.3 Pfizer Inc. Melanocortin Receptor 4 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Palatin Technologies, Inc.
      • 14.4.1 Company Information
      • 14.4.2 Melanocortin Receptor 4 Product Introduction
      • 14.4.3 Palatin Technologies, Inc. Melanocortin Receptor 4 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Obexia AG
      • 14.5.1 Company Information
      • 14.5.2 Melanocortin Receptor 4 Product Introduction
      • 14.5.3 Obexia AG Melanocortin Receptor 4 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Mallinckrodt Plc
      • 14.6.1 Company Information
      • 14.6.2 Melanocortin Receptor 4 Product Introduction
      • 14.6.3 Mallinckrodt Plc Melanocortin Receptor 4 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 AstraZeneca Plc
      • 14.7.1 Company Information
      • 14.7.2 Melanocortin Receptor 4 Product Introduction
      • 14.7.3 AstraZeneca Plc Melanocortin Receptor 4 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis

    ...

      15 Conclusion

        16 Methodology

        Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Melanocortin Receptor 4 market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Melanocortin Receptor 4 market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

        Segmented by Category
        Bremelanotide
        Corticotropin
        Cosyntropin
        Others

        Segmented by End User/Segment
        Metabolic Disorder
        Women's Health
        Genito Urinary System
        Infection Disease
        Others

        Segmented by Country
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
        Central & South America
        Brazil
        Argentina
        Colombia
        Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

        Key manufacturers included in this survey
        Rhythm Pharmaceuticals, Inc.
        Retrophin Inc.
        Pfizer Inc.
        Palatin Technologies, Inc.
        Obexia AG
        Mallinckrodt Plc
        AstraZeneca Plc


        Summary:
        Get latest Market Research Reports on Melanocortin Receptor 4. Industry analysis & Market Report on Melanocortin Receptor 4 is a syndicated market report, published as Dynamics in Post-pandemic Global Melanocortin Receptor 4 Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Melanocortin Receptor 4 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,980.00
        $4,470.00
        $5,960.00
        2,166.46
        3,249.69
        4,332.92
        2,527.04
        3,790.56
        5,054.08
        329,200.60
        493,800.90
        658,401.20
        221,861.00
        332,791.50
        443,722.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report